Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in July 28.06.2022 / 12:30 The issuer is solely responsible for the
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in July 28.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic to Participate in Industry and Scientific Conferences in July NEW YORK, June 28,.
08.06.2022 - Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Scientific, Industry and Investor Conferences in June 08.06.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to . Seite 1
/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused.
DGAP-News: Immunic, Inc. / Key word(s): Conference/Study results Immunic to Present Preclinical Data for Vidofludimus Calcium at the 17th Congress of ECCO and Announces Blinded Baseline Characteristics